Cargando…
The Role of Clinical Pharmacists in Improving Quality of Care in Patients with Inflammatory Bowel Disease: An Evaluation of Patients’ and Physicians’ Satisfaction
Background: Inflammatory bowel disease (IBD) is a chronic and complex disease that requires a multidisciplinary team, including clinical pharmacists, to improve the quality of care and patient outcome. This present study aimed to assess the satisfaction of patients with IBD and physicians regarding...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602087/ https://www.ncbi.nlm.nih.gov/pubmed/36292267 http://dx.doi.org/10.3390/healthcare10101818 |
_version_ | 1784817226292920320 |
---|---|
author | Alrashed, Fatema Almutairi, Najlaa Shehab, Mohammad |
author_facet | Alrashed, Fatema Almutairi, Najlaa Shehab, Mohammad |
author_sort | Alrashed, Fatema |
collection | PubMed |
description | Background: Inflammatory bowel disease (IBD) is a chronic and complex disease that requires a multidisciplinary team, including clinical pharmacists, to improve the quality of care and patient outcome. This present study aimed to assess the satisfaction of patients with IBD and physicians regarding clinical pharmacist interventions in outpatient and inpatient settings. Methods: A survey-based study was performed between 1 March and 1 August 2022 in a tertiary care IBD center. Two different questionnaires were distributed among patients and physicians focusing on satisfaction with the clinical pharmacist services. Patient demographics were obtained. Descriptive statistics were used to summarize the results of the survey. Results: A total of 108 patients with IBD and 23 physicians participated in this study. Among study participants, Crohn’s disease (CD) accounted for 64.8% of the total participants, while 35.2% of patients had ulcerative colitis (UC). Regarding the patient survey, most patients were extremely satisfied with clinical pharmacists’ services, during which the majority strongly agreed or agreed that they were satisfied with the counseling session. However, five patients were unsure about the amount of time spent with the clinical pharmacist. There were no patients dissatisfied with any of the services. Finally, two physicians were not sure regarding clinical pharmacists monitoring patients’ responses in of terms of toxicity and adverse effects. Conclusions: the current study illustrates patients’ and physicians’ high satisfaction with clinical pharmacists’ services in outpatient and inpatient settings. The findings of this study as well as previous studies necessitate expanding the clinical pharmacist services in the gastroenterology field. |
format | Online Article Text |
id | pubmed-9602087 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96020872022-10-27 The Role of Clinical Pharmacists in Improving Quality of Care in Patients with Inflammatory Bowel Disease: An Evaluation of Patients’ and Physicians’ Satisfaction Alrashed, Fatema Almutairi, Najlaa Shehab, Mohammad Healthcare (Basel) Article Background: Inflammatory bowel disease (IBD) is a chronic and complex disease that requires a multidisciplinary team, including clinical pharmacists, to improve the quality of care and patient outcome. This present study aimed to assess the satisfaction of patients with IBD and physicians regarding clinical pharmacist interventions in outpatient and inpatient settings. Methods: A survey-based study was performed between 1 March and 1 August 2022 in a tertiary care IBD center. Two different questionnaires were distributed among patients and physicians focusing on satisfaction with the clinical pharmacist services. Patient demographics were obtained. Descriptive statistics were used to summarize the results of the survey. Results: A total of 108 patients with IBD and 23 physicians participated in this study. Among study participants, Crohn’s disease (CD) accounted for 64.8% of the total participants, while 35.2% of patients had ulcerative colitis (UC). Regarding the patient survey, most patients were extremely satisfied with clinical pharmacists’ services, during which the majority strongly agreed or agreed that they were satisfied with the counseling session. However, five patients were unsure about the amount of time spent with the clinical pharmacist. There were no patients dissatisfied with any of the services. Finally, two physicians were not sure regarding clinical pharmacists monitoring patients’ responses in of terms of toxicity and adverse effects. Conclusions: the current study illustrates patients’ and physicians’ high satisfaction with clinical pharmacists’ services in outpatient and inpatient settings. The findings of this study as well as previous studies necessitate expanding the clinical pharmacist services in the gastroenterology field. MDPI 2022-09-21 /pmc/articles/PMC9602087/ /pubmed/36292267 http://dx.doi.org/10.3390/healthcare10101818 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Alrashed, Fatema Almutairi, Najlaa Shehab, Mohammad The Role of Clinical Pharmacists in Improving Quality of Care in Patients with Inflammatory Bowel Disease: An Evaluation of Patients’ and Physicians’ Satisfaction |
title | The Role of Clinical Pharmacists in Improving Quality of Care in Patients with Inflammatory Bowel Disease: An Evaluation of Patients’ and Physicians’ Satisfaction |
title_full | The Role of Clinical Pharmacists in Improving Quality of Care in Patients with Inflammatory Bowel Disease: An Evaluation of Patients’ and Physicians’ Satisfaction |
title_fullStr | The Role of Clinical Pharmacists in Improving Quality of Care in Patients with Inflammatory Bowel Disease: An Evaluation of Patients’ and Physicians’ Satisfaction |
title_full_unstemmed | The Role of Clinical Pharmacists in Improving Quality of Care in Patients with Inflammatory Bowel Disease: An Evaluation of Patients’ and Physicians’ Satisfaction |
title_short | The Role of Clinical Pharmacists in Improving Quality of Care in Patients with Inflammatory Bowel Disease: An Evaluation of Patients’ and Physicians’ Satisfaction |
title_sort | role of clinical pharmacists in improving quality of care in patients with inflammatory bowel disease: an evaluation of patients’ and physicians’ satisfaction |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602087/ https://www.ncbi.nlm.nih.gov/pubmed/36292267 http://dx.doi.org/10.3390/healthcare10101818 |
work_keys_str_mv | AT alrashedfatema theroleofclinicalpharmacistsinimprovingqualityofcareinpatientswithinflammatoryboweldiseaseanevaluationofpatientsandphysicianssatisfaction AT almutairinajlaa theroleofclinicalpharmacistsinimprovingqualityofcareinpatientswithinflammatoryboweldiseaseanevaluationofpatientsandphysicianssatisfaction AT shehabmohammad theroleofclinicalpharmacistsinimprovingqualityofcareinpatientswithinflammatoryboweldiseaseanevaluationofpatientsandphysicianssatisfaction AT alrashedfatema roleofclinicalpharmacistsinimprovingqualityofcareinpatientswithinflammatoryboweldiseaseanevaluationofpatientsandphysicianssatisfaction AT almutairinajlaa roleofclinicalpharmacistsinimprovingqualityofcareinpatientswithinflammatoryboweldiseaseanevaluationofpatientsandphysicianssatisfaction AT shehabmohammad roleofclinicalpharmacistsinimprovingqualityofcareinpatientswithinflammatoryboweldiseaseanevaluationofpatientsandphysicianssatisfaction |